Redwood Pharma will receive approximately SEK 2.1 million
In connection with convertible bond issues during the period July 2018 - January 2019, Redwood Pharma issued 287,958 warrants expiring on various occasions during 2021 and the beginning of 2022. After recalculation due to the rights issue in September 2019, the warrants entitle the holder to subscribe for a total of 293,716 shares. The holder of the warrants has today used all of these to subscribe for new shares. Redwood Pharma will thus receive approximately SEK 2.1 million. The subscription increases the number of shares in Redwood Pharma by 293,716 from 14,698,693 to 14,992,409.